Overview

Lornoxicam Versus Etodolac After Third Molar Surgery

Status:
Completed
Trial end date:
2022-09-29
Target enrollment:
0
Participant gender:
All
Summary
Our study aimed to compare the effect of lornoxicam and etodolac on postoperative pain, edema and trismus following lower third molar extraction
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Kutahya Health Sciences University
Treatments:
Etodolac
Lornoxicam
Criteria
Inclusion Criteria:

- Bilateral mesioangular impacted lower third molar

- Asymptomatic Third Molar (No history of infection)

- Systemically Healthy Person

- Person Between aged 18-30

Exclusion Criteria:

- People who are pregnant and lactation process

- People who had any systemic disease

- People who are gastrointestinal problems

- People who are sensitive to drugs used in study

- Lower Third Molar associated with cysts and infections